Skip to main content
. 2022 Sep 2;12(9):1229. doi: 10.3390/biom12091229

Figure 2.

Figure 2

(A) Ensemble Machine Learning (EML) scores of healthy controls (CTRL, blue) and endometrial cancer (EC, orange)-affected patients; the red dashed line represents the Youden index-based optimized cut-off value. (B) Receiver operating characteristic (ROC) curve obtained by varying the cut-off value when applying the EML model to the test set. Dotted blue line represents the 95% confidence bounds.